Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus

Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus

Abstract Encephalomyocarditis virus (EMCV), a potential zoonotic pathogen, poses significant socioeconomic and public health challenges across various host species. Although EMCV rarely triggers severe clinical symptoms in humans, its widespread prevalence and unique biological characteristics under...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanfang Zhang, Zhiying Wang, Yaohui Fang, Qiong Zhu, Jie Fu, Sijing Hu, Jiayin Jin, Min Zhou, Xijia Liu, Danna Zhang, Shouwei Huang, Yali Deng, Lingling Xie, Shu Shen, Jing Ye, Fei Deng, Shengbo Cao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Animal Diseases
Subjects:
Encephalomyocarditis virus
Monoclonal antibody
Virus-like particles
Neutralizing activity
Therapeutic efficacy
Antiviral development
Online Access:https://doi.org/10.1186/s44149-024-00154-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s44149-024-00154-7

Similar Items